GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi Consumer Healthcare India Ltd (NSE:SANOFICONR) » Definitions » Debt-to-Asset

Sanofi Consumer Healthcare India (NSE:SANOFICONR) Debt-to-Asset : 0.00 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Sanofi Consumer Healthcare India Debt-to-Asset?

Sanofi Consumer Healthcare India's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹0 Mil. Sanofi Consumer Healthcare India's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹0 Mil. Sanofi Consumer Healthcare India's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2025 was ₹0 Mil.


Sanofi Consumer Healthcare India Debt-to-Asset Historical Data

The historical data trend for Sanofi Consumer Healthcare India's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Consumer Healthcare India Debt-to-Asset Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24
Debt-to-Asset
- 0.05

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Debt-to-Asset Get a 7-Day Free Trial - - - 0.05 -

Competitive Comparison of Sanofi Consumer Healthcare India's Debt-to-Asset

For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi Consumer Healthcare India's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Sanofi Consumer Healthcare India's Debt-to-Asset falls into.


;
;

Sanofi Consumer Healthcare India Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Sanofi Consumer Healthcare India's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Sanofi Consumer Healthcare India's Debt-to-Asset for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi Consumer Healthcare India  (NSE:SANOFICONR) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Sanofi Consumer Healthcare India Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Sanofi Consumer Healthcare India's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Consumer Healthcare India Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, L&T business park, 3rd Floor, Sanofi House, CTS No. 117-B, Powai, Mumbai, MH, IND, 400072
Sanofi Consumer Healthcare India Ltd is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all varieties of pharmaceuticals especially consumer healthcare products.

Sanofi Consumer Healthcare India Headlines

No Headlines